Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  2016-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00262-015-1771-8PMID 26590829PMCID PMC11028616
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 143 The Combination of anti-TIM-3 and anti-PD-1 Checkpoint Inhibitors With Focused Radiation Resulted in a Synergistic Antitumor Immune Response in a Preclinical Glioma Model

  2015cited by this paper
• Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial.

  2015cited by this paper
• Radiation and Dual Checkpoint Blockade Activates Non-Redundant Immune Mechanisms in Cancer

  2015cited by this paper
• Modulation of inflammation by low and high doses of ionizing radiation: Implications for benign and malign diseases.

  2015cited by this paper
• The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence

  2015cited by this paper
• Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner

  2015cited by this paper
• Radiotherapy complements immune checkpoint blockade.

  2015cited by this paper
• Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) – From Preclinical Studies to a Clinical Phase II Trial

  2015cited by this paper
• Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies.

  2015cited by this paper
• Update on checkpoint blockade therapy for lymphoma

  2015cited by this paper
• Immune checkpoint targeting as anti-cancer immunotherapy: promises, questions, challenges and the need for predictive biomarkers at ASCO 2015

  2015cited by this paper
• Immune checkpoint inhibitors in melanoma provide the cornerstones for curative therapies.

  2015cited by this paper
• Radio-immunotherapy: the focused beam expands.

  2015cited by this paper
• Low and moderate doses of ionizing radiation up to 2 Gy modulate transmigration and chemotaxis of activated macrophages, provoke an anti‐inflammatory cytokine milieu, but do not impact upon viability and phagocytic function

  2015cited by this paper
• Kill and spread the word: stimulation of antitumor immune responses in the context of radiotherapy.

  2014cited by this paper
• Consensus guidelines for the detection of immunogenic cell death

  2014cited by this paper
• Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade.

  2014cited by this paper
• Immune modulation in cancer with antibodies.

  2014cited by this paper
• Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2C.

  2014cited by this paper
• Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice.

  2014cited by this paper
• Norm- and hypo-fractionated radiotherapy is capable of activating human dendritic cells

  2014cited by this paper
• New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape.

  2014cited by this paper
• Combinations of radiation therapy and immunotherapy for melanoma: a review of clinical outcomes.

  2014cited by this paper
• Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas.

  2013cited by this paper
• Breakthrough of the year 2013. Cancer immunotherapy.

  2013cited by this paper
• Antitumor immune responses induced by ionizing irradiation and further immune stimulation

  2013cited by this paper
• Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy.

  2013cited by this paper
• Signatures of mutational processes in human cancer

  2013cited by this paper
• The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors.

  2012cited by this paper
• Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodies.

  2012cited by this paper
• Induction of abscopal anti-tumor immunity and immunogenic tumor cell death by ionizing irradiation - implications for cancer therapies.

  2012cited by this paper
• Trial Watch

  2012cited by this paper
• How Does Ionizing Irradiation Contribute to the Induction of Anti-Tumor Immunity?

  2012cited by this paper
• The blockade of immune checkpoints in cancer immunotherapy

  2012cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity.

  2011cited by this paper
• Editorial. Non-DNA targeted effects.

  2010cited by this paper
• Molecular mechanisms of necroptosis: an ordered cellular explosion

  2010cited by this paper
• Immunity, inflammation, and cancer.

  2010cited by this paper
• Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody

  2009cited by this paper
• Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

  2007cited by this paper
• Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer.

  2005cited by this paper
• Classification of cell death: recommendations of the Nomenclature Committee on Cell Death

  2005cited by this paper
• Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009

  2005cited by this paper
• CpG Motifs as Proinflammatory Factors Render Autochthonous Tumors Permissive for Infiltration and Destruction1

  2004cited by this paper
• The immunobiology of cancer immunosurveillance and immunoediting.

  2004cited by this paper
• Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated.

  2004cited by this paper
• Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication.

  2002cited by this paper

• VISTA: bridging gaps in cancer immunotherapy.

  2026cites this paper
• Novel Immunotherapeutic Approaches for Patients with Head and Neck Cutaneous Squamous Cell Carcinoma

  2026cites this paper
• A prospective observational study of inflammatory mediators in cerebrospinal fluid after intraoperative radiotherapy of brain tumors

  2025cites this paper
• AI-Enhanced Synergistic Chemo-Immunotherapy: From Mechanistic Insights to Clinical Translation.

  2025cites this paper
• m6A-driven transcriptomic rewiring in tumor immune surveillance

  2025cites this paper
• PD-L1 Expression in Paired Samples of Rectal Cancer

  2024cites this paper
• Efficacy and safety of combining radiotherapy with immune checkpoint inhibitors in patients with advanced non-small cell lung cancer: a real-world study

  2024cites this paper
• Bispecific Antibodies, Immune Checkpoint Inhibitors, and Antibody−Drug Conjugates Directing Antitumor Immune Responses: Challenges and Prospects

  2024cites this paper
• Can we safely de-escalate HPV+ oropharyngeal cancers? - A review of current practices and novel approaches.

  2024cites this paper
• Combination Immunotherapy With Radiotherapy in Non‐Small Cell Lung Cancer: A Review of Evidence

  2024cites this paper
• SOX13 as a potential prognostic biomarker linked to immune infiltration and ferroptosis inhibits the proliferation, migration, and metastasis of thyroid cancer cells

  2024cites this paper
• Non-operative management after immune checkpoint inhibitors for early-stage, dMMR/MSI-H gastrointestinal cancers.

  2024cites this paper
• Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics

  2024cites this paper
• A new target of radiotherapy combined with immunotherapy: regulatory T cells

  2024cites this paper
• Case report: Interstitial implantation radiotherapy combined with immunotherapy and GM-CSF in oligometastatic platinum-resistant ovarian cancer

  2024cites this paper
• Medical gas plasma technology: Roadmap on cancer treatment and immunotherapy

  2023cites this paper
• Repositioning of FDA approved kinase inhibitor bosutinib for mitigation of radiation induced damage via inhibition of JNK pathway.

  2023cites this paper
• Selenium-Containing Nanocomplexes Achieve Dual Immune Checkpoint Blockade for NK Cell Reinvigoration.

  2023cites this paper
• Phase II trial of Concurrent Nivolumab and Radiation therapy in Elderly or Chemotherapy ineligible Muscle Invasive Bladder Cancer.

  2023cites this paper
• Potential targets and applications of nanodrug targeting myeloid cells in osteosarcoma for the enhancement of immunotherapy

  2023cites this paper
• Application value of self-management manual combined with case management superiority model in postoperative management of nasopharyngeal carcinoma after radiotherapy.

  2023cites this paper
• Modulation of PD-L1 expression by standard therapy in head and neck cancer cell lines and exosomes

  2023cites this paper
• Tackling the current dilemma of immunotherapy in extensive-stage small cell lung cancer: A promising strategy of combining with radiotherapy.

  2023cites this paper
• Tumor Treating Fields (TTFields) Concomitant with Immune Checkpoint Inhibitors Are Therapeutically Effective in Non-Small Cell Lung Cancer (NSCLC) In Vivo Model

  2022cites this paper
• Nanoparticle‐Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor Efficacy

  2022cites this paper
• Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment

  2022influential citation
• Recent progress in cancer immunotherapy: Overview of current status and challenges.

  2022cites this paper
• HIF-1α/IL-8 axis in hypoxic macrophages promotes esophageal cancer progression by enhancing PD-L1 expression

  2022cites this paper
• Blood Immune Cell Biomarkers in Lung Cancer Patients Undergoing Treatment with a Combination of Chemotherapy and Immune Checkpoint Blockade

  2022cites this paper
• Development of In Vitro Assays for Advancing Radioimmunotherapy against Brain Tumors

  2022cites this paper
• Immune checkpoint inhibitors in metastatic colorectal cancer therapy (a review)

  2022cites this paper
• Gamma Irradiation Triggers Immune Escape in Glioma-Propagating Cells

  2022cites this paper
• Rationale and design of a prospective, multicenter, phase II clinical trial of safety and efficacy evaluation of long course neoadjuvant chemoradiotherapy plus tislelizumab followed by total mesorectal excision for locally advanced rectal cancer (NCRT-PD1-LARC trial)

  2022cites this paper
• Immune Checkpoint Inhibitors in Cancer Therapy

  2022cites this paper
• Revolutionization in Cancer Therapeutics via Targeting Major Immune Checkpoints PD-1, PD-L1 and CTLA-4

  2022cites this paper
• Enhanced toxicity to chemoradiation in a patient with Anti-Jo-1-antisynthetase syndrome

  2022cites this paper
• Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier

  2022cites this paper
• Paving the Way for Immunotherapy in Pediatric Acute Myeloid Leukemia: Current Knowledge and the Way Forward

  2021cites this paper
• Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial

  2021cites this paper
• Small-Molecule Prodrug Nanoassemblies: An Emerging Nanoplatform for Anticancer Drug Delivery.

  2021cites this paper
• A Prospective Real-World Multi-Center Study to Evaluate Progression-Free and Overall Survival of Radiotherapy with Cetuximab and Platinum-Based Chemotherapy with Cetuximab in Locally Recurrent Head and Neck Cancer

  2021cites this paper
• Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer

  2021cites this paper
• Immune Checkpoint Inhibitor‐Based Strategies for Synergistic Cancer Therapy

  2021cites this paper
• Nanocarrier-Based Drug Delivery for Melanoma Therapeutics

  2021cites this paper
• Bladder preservation therapy in combination with atezolizumab and radiation therapy for invasive bladder cancer (BPT-ART) – A study protocol for an open-label, phase II, multicenter study

  2021cites this paper
• Head and neck tumor cells treated with hypofractionated irradiation die via apoptosis and are better taken up by M1-like macrophages

  2021cites this paper
• Review on combination strategy of immune checkpoint blockade, photodynamic therapy and nanomedicine against solid tumor

  2021cites this paper
• Immunotherapy in cervix cancer.

  2020cites this paper
• Increased effect of two-fraction radiotherapy in conjunction with IDO1 inhibition in experimental glioblastoma

  2020cites this paper
• Proton scanning and X-ray beam irradiation induce distinct regulation of inflammatory cytokines in a preclinical mouse model

  2020cites this paper
• Human Forebrain Organoids from Induced Pluripotent Stem Cells: A Novel Approach to Model Repair of Ionizing Radiation-Induced DNA Damage in Human Neurons

  2020cites this paper
• Infiltrating immune cells are associated with radiosensitivity and favorable survival in head and neck cancer treated with definitive radiotherapy.

  2020cites this paper
• Improving responses to immunotherapy in head and neck squamous cell carcinoma

  2020cites this paper
• Combination of Gas Plasma and Radiotherapy Has Immunostimulatory Potential and Additive Toxicity in Murine Melanoma Cells In Vitro

  2020cites this paper
• Erste erfolgversprechende Ergebnisse der Kombination aus Strahlentherapie und Pembrolizumab beim metastasierten nichtkleinzelligen Lungenkarzinom

  2020cites this paper
• Analysis of the immune status from peripheral whole blood with a single-tube multicolor flow cytometry assay.

  2020cites this paper
• Clinical application of immune checkpoints in targeted immunotherapy of prostate cancer

  2020cites this paper
• The role of radiation induced oxidative stress as a regulator of radio-adaptive responses

  2020cites this paper
• The prognostic value of the ratio of neutrophils to lymphocytes before and after intensity modulated radiotherapy for patients with nasopharyngeal carcinoma

  2020cites this paper
• Damage-associated molecular patterns in tumor radiotherapy.

  2020cites this paper
• Outcome after autologous stem cell transplantation in primary refractory or relapsed Hodgkin lymphoma—a long-term follow-up single center experience

  2020cites this paper
• Photothermal therapies to improve immune checkpoint blockade for cancer

  2020cites this paper
• Combination Therapies with Y90: Immunoradiation

  2020cites this paper
• Gastric cancer mesenchymal stem cells regulate PD-L1-CTCF enhancing cancer stem cell-like properties and tumorigenesis

  2020cites this paper
• Role of Postoperative Radiotherapy in Nonmetastatic Head and Neck Adenoid Cystic Carcinoma.

  2020cites this paper
• STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects

  2020cites this paper
• Prospective Evaluation of All-lesion Versus Single-lesion Radiotherapy in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors

  2020cites this paper
• Narrative review of immunotherapy and radiation therapy in elderly patients

  2020cites this paper
• Addition of Radiotherapy to Immunotherapy: Effects on Outcome of Different Subgroups Using a Propensity Score Matching

  2020cites this paper
• Erste erfolgversprechende Ergebnisse beim metastasierten NSCLC

  2020cites this paper
• Enhanced Radiation Sensitivity of Human Papillomavirus-Driven Head and Neck Cancer: Focus on Immunological Aspects

  2019cites this paper
• NADPH Oxidase as a Target for Modulation of Radiation Response; Implications to Carcinogenesis and Radiotherapy.

  2019cites this paper
• Rationale for combination of radiation therapy and immune checkpoint blockers to improve cancer treatment

  2019cites this paper
• CCR2-Dependent Recruitment of Tregs and Monocytes Following Radiotherapy Is Associated with TNFα-Mediated Resistance

  2019cites this paper
• Neoadjuvant Radiochemotherapy Significantly Alters the Phenotype of Plasmacytoid Dendritic Cells and 6-Sulfo LacNAc+ Monocytes in Rectal Cancer

  2019cites this paper
• Radiotherapy Both Promotes and Inhibits Myeloid-Derived Suppressor Cell Function: Novel Strategies for Preventing the Tumor-Protective Effects of Radiotherapy

  2019cites this paper
• Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy

  2019cites this paper
• Radiotherapy for Melanoma: More than DNA Damage

  2019cites this paper
• Impact of inflammatory signaling on radiation biodosimetry: mouse model of inflammatory bowel disease

  2019cites this paper
• Radiotherapy in combination with nivolumab for relapsed/refractory classical Hodgkin lymphoma: About two cases.

  2019cites this paper
• Recent advances in nanomaterial-based synergistic combination cancer immunotherapy.

  2019cites this paper
• Tumor Microenvironment as A “Game Changer” in Cancer Radiotherapy

  2019cites this paper
• Immune checkpoint blockade in glioma

  2019cites this paper
• The pro-tumorigenic host response to cancer therapies

  2019cites this paper
• Diselenide-Pemetrexed Assemblies for Combined Cancer Immuno-, Radio-, and Chemotherapies.

  2019cites this paper
• Systemic Immunostimulatory Effects of Radiation Therapy Improves the Outcomes of Patients With Advanced NSCLC Receiving Immunotherapy

  2019cites this paper
• Antibody targeting of phosphatidylserine for the detection and immunotherapy of cancer

  2018cites this paper
• Wnt Signalling-Targeted Therapy in the CMS2 Tumour Subtype: A New Paradigm in CRC Treatment?

  2018cites this paper
• Progress in low dose health risk research: Novel effects and new concepts in low dose radiobiology.

  2018cites this paper
• Combining Radiotherapy and Immunotherapy in Lung Cancer: Can We Expect Limitations Due to Altered Normal Tissue Toxicity?

  2018cites this paper
• Targeting malignant melanoma with physical plasmas

  2018cites this paper
• Radiothérapie interne vectorisée appliquée aux synovialosarcomes : mise en place d'une étude de phase 1

  2018cites this paper
• Self-Supplied Tumor Oxygenation through Separated Liposomal Delivery of H2O2 and Catalase for Enhanced Radio-Immunotherapy of Cancer.

  2018cites this paper
• Long-term Survival of Locally Advanced Stage III Non-small Cell Lung Cancer Patients Treated with Chemoradiotherapy and Perspectives for The Treatment with Immunotherapy

  2018cites this paper
• Unfavorable clinical implications of peripheral blood CD44+ and CD54+ lymphocytes in patients with lung cancer undergoing chemotherapy

  2018cites this paper
• Flow Cytometric Analysis of Depletion and Recovery Kinetics of T Cell Subsets in Rats After Total-Body- Irradiation: Footprints of Treg-Augmented Immunosuppression

  2018cites this paper
• Gastric cancer mesenchymal stem cells derived IL-8 induces PD-L1 expression in gastric cancer cells via STAT3/mTOR-c-Myc signal axis

  2018cites this paper
• Inhibiting the CD8+ T cell infiltration in the tumor microenvironment after radiotherapy is an important mechanism of radioresistance

  2018cites this paper
• The Role of Immune Checkpoint Inhibitors in Classical Hodgkin Lymphoma

  2018cites this paper
• Inhibition of survivin enhances radiosensitivity of esophageal cancer cells by switching radiation-induced senescence to apoptosis

  2018cites this paper